Literature DB >> 23770471

Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor.

Laurie C Zephyrin1, Kimberly N Hong, Ronald J Wapner, Alan M Peaceman, Yoram Sorokin, Donald J Dudley, Jay D Iams, Margaret Harper, Steve N Caritis, Brian M Mercer, John M Thorp, Susan M Ramin, Dwight J Rouse, Baha Sibai.   

Abstract

OBJECTIVE: The purpose of this study was to estimate a gestational age threshold at which the benefits of treatment with weekly courses of antenatal corticosteroids (ACS) during preterm labor outweigh the risks. STUDY
DESIGN: Risk-benefit ratios by gestational age were determined with the use of a Markov microsimulation decision-analysis model with a 1-week cycle length. Single course and multiple (weekly to a maximum of 4) courses of ACS by gestational age of entry (23 weeks to 31 weeks 6 days' gestation) were compared. Benefits were composite events (respiratory distress syndrome, chronic lung disease, severe intraventricular hemorrhage, periventricular leukomalacia, bronchopulmonary dysplasia, or stillbirth) averted. Risks were small head circumference and small for gestational age.
RESULTS: More composite events are averted (benefits) than risks acquired (ratio, 6:1) when multiple courses of ACS are initiated at 26 weeks' gestation. When multiple courses of ACS are initiated at 29 weeks' gestation, the risk-benefit ratio is 1. Beyond 29 weeks, there is a suggestion of more risk than benefit.
CONCLUSION: The model suggests that multiple courses of ACS that are initiated at <29 weeks' gestation may have increased benefit compared with risks. Further analyses are needed to determine the long-term clinical significance of these findings.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  antenatal corticosteroid; decision analysis; preterm labor

Mesh:

Substances:

Year:  2013        PMID: 23770471      PMCID: PMC3967787          DOI: 10.1016/j.ajog.2013.06.009

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender.

Authors:  G R Alexander; M D Kogan; J H Himes
Journal:  Matern Child Health J       Date:  1999-12

2.  Repeated antenatal corticosteroids: size at birth and subsequent development.

Authors:  N P French; R Hagan; S F Evans; M Godfrey; J P Newnham
Journal:  Am J Obstet Gynecol       Date:  1999-01       Impact factor: 8.661

3.  Antenatal glucocorticoid treatment for preterm birth: considerations for the developing foetus.

Authors:  Rebecca M Reynolds
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05       Impact factor: 3.478

Review 4.  Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.

Authors:  Caroline A Crowther; Christopher Jd McKinlay; Philippa Middleton; Jane E Harding
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 5.  Single versus repeat courses of antenatal steroids to improve neonatal outcomes: risks and benefits.

Authors:  Clarissa Bonanno; Karin Fuchs; Ronald J Wapner
Journal:  Obstet Gynecol Surv       Date:  2007-04       Impact factor: 2.347

6.  Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.

Authors:  Caroline A Crowther; Ross R Haslam; Janet E Hiller; Lex W Doyle; Jeffrey S Robinson
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

7.  Long-term outcomes after repeat doses of antenatal corticosteroids.

Authors:  Ronald J Wapner; Yoram Sorokin; Lisa Mele; Francee Johnson; Donald J Dudley; Catherine Y Spong; Alan M Peaceman; Kenneth J Leveno; Fergal Malone; Steve N Caritis; Brian Mercer; Margaret Harper; Dwight J Rouse; John M Thorp; Susan Ramin; Marshall W Carpenter; Steven G Gabbe
Journal:  N Engl J Med       Date:  2007-09-20       Impact factor: 91.245

8.  Outcomes at 2 years of age after repeat doses of antenatal corticosteroids.

Authors:  Caroline A Crowther; Lex W Doyle; Ross R Haslam; Janet E Hiller; Jane E Harding; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2007-09-20       Impact factor: 91.245

9.  Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial.

Authors:  Kellie E Murphy; Mary E Hannah; Andrew R Willan; Sheila A Hewson; Arne Ohlsson; Edmond N Kelly; Stephen G Matthews; Saroj Saigal; Elizabeth Asztalos; Susan Ross; Marie-France Delisle; Kofi Amankwah; Patricia Guselle; Amiram Gafni; Shoo K Lee; B Anthony Armson
Journal:  Lancet       Date:  2008-12-20       Impact factor: 79.321

10.  Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial.

Authors:  Thomas J Garite; James Kurtzman; Kimberly Maurel; Reese Clark
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

View more
  7 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

2.  The Joint Effects of Antenatal Steroids and Gestational Age on Improved Outcomes in Neonates.

Authors:  Neal D Goldstein; Kaitlin M Kenaley; Robert Locke; David A Paul
Journal:  Matern Child Health J       Date:  2018-03

3.  Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth.

Authors:  Anke C Rohwer; Olufemi T Oladapo; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2020-05-26

4.  Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study.

Authors:  Colm P Travers; Reese H Clark; Alan R Spitzer; Abhik Das; Thomas J Garite; Waldemar A Carlo
Journal:  BMJ       Date:  2017-03-28

5.  A Retrospective Database Analysis of Neonatal Morbidities to Evaluate a Composite Endpoint for Use in Preterm Labor Clinical Trials.

Authors:  Jeanne M Pimenta; Myla Ebeling; Timothy H Montague; Kathleen J Beach; Jill Abell; Michael T O'Shea; Marcy Powell; Thomas C Hulsey
Journal:  AJP Rep       Date:  2018-03-07

6.  Administration of Antenatal Corticosteroids: Current State of Knowledge.

Authors:  Richard Berger; Ioannis Kyvernitakis; Holger Maul
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-01-11       Impact factor: 2.915

Review 7.  Maternal hormonal milieu influence on fetal brain development.

Authors:  Alexandra Miranda; Nuno Sousa
Journal:  Brain Behav       Date:  2018-01-24       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.